Knop RH - Search Results

1

UDP-N-acetylhexosamine modulation by glucosamine and uridine in NCI N-417 variant small cell lung cancer cells: 31P nuclear magnetic resonance results.

Pederson NV, Knop RH, Miller WM. Pederson NV, et al. Among authors: knop rh. Cancer Res. 1992 Jul 1;52(13):3782-6. Cancer Res. 1992. PMID: 1319832

2

Discrimination of fluorinated uridine metabolites in N-417 small cell lung cancer cell extracts via 19F- and 31P-NMR.

Pederson NV, Zanghi JA, Miller WM, Knop RH. Pederson NV, et al. Among authors: knop rh. Magn Reson Med. 1994 Feb;31(2):224-8. doi: 10.1002/mrm.1910310217. Magn Reson Med. 1994. PMID: 8133759

3

Ammonia inhibits neural cell adhesion molecule polysialylation in Chinese hamster ovary and small cell lung cancer cells.

Zanghi JA, Mendoza TP, Knop RH, Miller WM. Zanghi JA, et al. Among authors: knop rh. J Cell Physiol. 1998 Nov;177(2):248-63. doi: 10.1002/(SICI)1097-4652(199811)177:2<248::AID-JCP7>3.0.CO;2-N. J Cell Physiol. 1998. PMID: 9766522

4

Role of nucleotide sugar pools in the inhibition of NCAM polysialylation by ammonia.

Zanghi JA, Mendoza TP, Schmelzer AE, Knop RH, Miller WM. Zanghi JA, et al. Among authors: knop rh. Biotechnol Prog. 1998 Nov-Dec;14(6):834-44. doi: 10.1021/bp9800945. Biotechnol Prog. 1998. PMID: 9841644

5

Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO(2) or pH.

Zanghi JA, Schmelzer AE, Mendoza TP, Knop RH, Miller WM. Zanghi JA, et al. Among authors: knop rh. Biotechnol Bioeng. 1999 Oct 20;65(2):182-91. doi: 10.1002/(sici)1097-0290(19991020)65:2<182::aid-bit8>3.0.co;2-d. Biotechnol Bioeng. 1999. PMID: 10458739

6

Levels of high energy phosphates in human lung cancer cell lines by 31P nuclear magnetic resonance spectroscopy.

Knop RH, Carney DN, Chen CW, Cohen JS, Minna JD. Knop RH, et al. Cancer Res. 1987 Jul 1;47(13):3357-9. Cancer Res. 1987. PMID: 3034411

7

Detecting fatty acids of dietary origin in normal and cancerous human breast tissue by 13C nuclear magnetic resonance spectroscopy.

Victor TA, Bergman A, Knop RH. Victor TA, et al. Among authors: knop rh. Br J Cancer. 1993 Aug;68(2):336-41. doi: 10.1038/bjc.1993.337. Br J Cancer. 1993. PMID: 8347488 Free PMC article.

8

Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.

Shevrin DH, Kilton LJ, Lad TE, Mullane M, Esparaz B, Knop R, Egner J, Johnson P, Blough R, French S, et al. Shevrin DH, et al. Invest New Drugs. 1994;12(4):345-6. doi: 10.1007/BF00873053. Invest New Drugs. 1994. PMID: 7775139 Clinical Trial. No abstract available.

9

Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma.

Carneiro BA, Brand RE, Fine E, Knop RH, Khandekar JD, Uhlig W, Locker GY. Carneiro BA, et al. Among authors: knop rh. Cancer Invest. 2007 Aug;25(5):366-71. doi: 10.1080/15368370701357957. Cancer Invest. 2007. PMID: 17661212 Clinical Trial.

10

Quantitative 19F NMR study of trifluorothymidine metabolism in rat brain.

Pouremad R, Bahk KD, Shen YJ, Knop RH, Wyrwicz AM. Pouremad R, et al. Among authors: knop rh. NMR Biomed. 1999 Oct;12(6):373-80. doi: 10.1002/(sici)1099-1492(199910)12:6<373::aid-nbm569>3.0.co;2-r. NMR Biomed. 1999. PMID: 10516619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters